CDRH User Fee Performance Standard Tied To Appropriations Under Scrutiny
This article was originally published in The Gray Sheet
Executive Summary
Language in the current device user fee proposal requiring CDRH to meet performance goals only if it receives $205.7 mil. in appropriations will likely be revised to assuage manufacturer concerns, industry reps believe
You may also be interested in...
User Fee Supporters Eye Rx Drug Bill, Other Vehicles In Coming Weeks
Proponents of HR 3580, user fees and language pertaining to reuse of single-use devices are looking beyond the ongoing Medicare prescription drug debate to find a more suitable legislative vehicle before the Senate recesses Aug. 5
Dems Support User Fees, Third-Party Provisions In Letter To House Leaders
House Democrats are urging Energy & Commerce Committee leaders to pass medical device reforms this congressional session
Kennedy To Industry: User Fees Still In Play If Third Party Sits This One Out
Industry supporters of medical device user fees are assuming a formidable challenge by linking the legislative proposal with the "Medical Device Amendments of 2001" (HR 3580), introduced by Reps. Jim Greenwood (R-Penn.) and Anna Eshoo (D-Calif.)